Concomitant EBV-related B-cell proliferation and juvenile myelomonocytic leukemia in a 2-year-old child

Leukemia Research

Volumn 32, Issue 1, 2008, Pages 181-184

  Janik Moszant, Anna ^a   Barć Czarnecka, Małgorzata ^a   van der Burg, Mirjam ^b   Langerak, Anton W ^b   Hartwig, Nico G ^b   Vossen, Ann C T M ^b   Niemeyer, Charlotte M ^c   Wachowiak, Jacek ^d   Sońta Jakimczyk, Danuta ^a   Szczepański, Tomasz ^a,b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF FREIBURG   (Germany)

^d POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Children; Epstein Barr virus; Juvenile myelomonocytic leukemia; N RAS mutation; Polyclonal B lymphoproliferation

Indexed keywords

CYTOKINE; HYDROXYUREA; MERCAPTOPURINE; RITUXIMAB;

ARTICLE; B LYMPHOCYTE; CASE REPORT; CLINICAL FEATURE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; JUVENILE MYELOMONOCYTIC LEUKEMIA; LEUKEMIA CELL; LYMPHOCYTE PROLIFERATION; MYELOID PROGENITOR CELL; ONCOGENE N RAS; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYMPTOM; VIRUS CELL INTERACTION; VIRUS INFECTION;

B-LYMPHOCYTES; CELL PROLIFERATION; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; LEUKEMIA, MYELOMONOCYTIC, JUVENILE; LYMPHOCYTOSIS;

EID: 36048994587     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.05.017     Document Type: Article

References (7)

1. van Wering E.R., van der Linden-Schrever B.E., Szczepański T., Willemse M.J., Baars E.A., van Wijngaarde-Schmitz H.M., et al. Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease. Br J Haematol 110 (2000) 139-146
2. van Dongen J.J.M., Langerak A.W., Bruggemann M., Evans P.A.S., Hummel M., Lavender F.L., et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia 17 (2003) 2257-2317
3. Coffey A.J., Brooksbank R.A., Brandau O., Oohashi T., Howell G.R., Bye J.M., et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 20 (1998) 129-135
4. Niemeyer C.M., and Locatelli F. Chronic myeloproliferative disorders. In: Pui C.-H. (Ed). Childhood Leukemias (2006), Cambridge University Press, Cambridge 571-598
5. Manabe A., Yoshimasu T., Ebihara Y., Yagasaki H., Wada M., Ishikawa K., et al. Viral infections in juvenile myelomonocytic leukemia: prevalence and clinical implications. J Pediatr Hematol Oncol 26 (2004) 636-641
6. Stollmann B., Fonatsch C., and Havers W. Persistent Epstein-Barr virus infection associated with monosomy 7 or chromosome 3 abnormality in childhood myeloproliferative disorders. Br J Haematol 60 (1985) 183-196
7. Pinkel D. Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood 91 (1998) 365-367